AssayIndex
Reports by quarter

Reports submitted in 2026-Q3

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.93 % area, n=455. Read the 2026-Q3 state-of-the-index report →

455 records12 pagesmedian on this page 99.17 %updated 30 Jul 2026
018365492.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=196.00–96.25 %: n=196.25–96.50 %: n=396.50–96.75 %: n=996.75–97.00 %: n=397.00–97.25 %: n=1097.25–97.50 %: n=1097.50–97.75 %: n=2097.75–98.00 %: n=2598.00–98.25 %: n=2398.25–98.50 %: n=4298.50–98.75 %: n=5398.75–99.00 %: n=5099.00–99.25 %: n=5699.25–99.50 %: n=4799.50–99.75 %: n=3899.75–100.00 %: n=64median 98.93 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2026-Q3. n=455, median 98.93 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043179Kisspeptin-10GL BiochemGLBI-2608-N7715Medutest2026-Q398.974.37—Buyer-sourced1MARGINAL
AX-2026-041776TB-500ASYASY-{CAT}-2167Janoshik2026-Q399.924.6198.2Buyer-sourced0PASS
AX-2026-042265Humanin (HNG)TFCTFC-2605-U1300PeptideMeter2026-Q399.526.31—Buyer-sourced0PASS
AX-2026-043535GHRP-2SIGSIG-2603-6031Janoshik2026-Q399.121.26105.7Buyer-sourced0PASS
AX-2026-043376SemaglutideWXTWXT-2604-C3248Janoshik2026-Q397.084.22—Buyer-sourced1MARGINAL
AX-2026-042437RetatrutideHomopeptideHOMO-2605-V4718Nordanalyt2026-Q398.683.67102.8Buyer-sourced0PASS
AX-2026-042222SS-31 (Elamipretide)TFCTFC-2607-R9099VendorInvestigate2026-Q399.465.41102.6Buyer-sourced0PASS
AX-2026-041831SurvodutideGSPGSP-2603-E3156Kestrel2026-Q399.915.5093.2Buyer-sourced0PASS
AX-2026-041275LiraglutideWWBWWB-2607-X2189Nordanalyt2026-Q399.334.39—Buyer-sourced1MARGINAL
AX-2026-043429L-Glutathione (reduced)WXTWXT-2605-B3833Nordanalyt2026-Q398.486.5896.9Supplier-supplied1FAIL
AX-2026-043095RetatrutideKPKP-2607-H5774Janoshik2026-Q395.815.48105.2Buyer-sourced0FAIL
AX-2026-042424SemaglutideHomopeptideHOMO-2604-X3806PeptideMeter2026-Q398.854.8792.0Buyer-sourced0PASS
AX-2026-042177HexarelinJEEPJEEP-2608-Y9547Janoshik2026-Q399.903.42—Buyer-sourced0PASS
AX-2026-041643SemaglutideFGPFGP-2602-M8547Janoshik2026-Q399.312.79100.7Buyer-sourced0PASS
AX-2026-041334SemaglutideWWBWWB-2606-N3192Janoshik2026-Q398.934.6299.9Buyer-sourced0PASS
AX-2026-042236Humanin (HNG)TFCTFC-2608-S9940Nordanalyt2026-Q398.641.80—Buyer-sourced0PASS
AX-2026-042002SemaglutideAMBAMB-2607-N6274VendorInvestigate2026-Q398.236.3797.1Buyer-sourced1MARGINAL
AX-2026-043541GHRP-2SIGSIG-2603-6031PeptideMeter2026-Q399.062.08107.4Buyer-sourced1MARGINAL
AX-2026-043319BPC-157CPCCPC-2602-W1610Medutest2026-Q398.822.88103.5Buyer-sourced2MARGINAL
AX-2026-042503IGF-1 LR3HomopeptideHOMO-2607-P5131Janoshik2026-Q399.365.99—Buyer-sourced0PASS
AX-2026-042282RetatrutideTFCTFC-2608-J1156Janoshik2026-Q398.544.27—Buyer-sourced0PASS
AX-2026-042083MOTS-cHYBHYB-2606-D7858Medutest2026-Q399.932.02—Buyer-sourced0PASS
AX-2026-041681CJC-1295 with DACTFSTFS-{CAT}-9675PeptideMeter2026-Q398.823.67—Buyer-sourced0PASS
AX-2026-041471PT-141 (Bremelanotide)QYBQYB-2607-L4875Janoshik2026-Q399.723.75101.7Buyer-sourced0PASS
AX-2026-041377IpamorelinQYBQYB-2605-H3558Nordanalyt2026-Q399.934.35—Buyer-sourced0PASS
AX-2026-043347LeuprolideWXTWXT-2604-K2596PeptideMeter2026-Q399.165.9993.6Buyer-sourced0PASS
AX-2026-043178Kisspeptin-10GL BiochemGLBI-2608-N7715Janoshik2026-Q398.504.55—Buyer-sourced1MARGINAL
AX-2026-042942CJC-1295 (no DAC)MKMMKM-2603-V3346Janoshik2026-Q399.523.43—Supplier-supplied0PASS
AX-2026-042492SS-31 (Elamipretide)HomopeptideHOMO-2604-D5484Medutest2026-Q399.932.40—Buyer-sourced0PASS
AX-2026-041867CJC-1295 with DACSinoPepSNP-2607-C3886Janoshik2026-Q399.245.12—Laboratory-retained1FAIL
AX-2026-041777TB-500ASYASY-{CAT}-2167PeptideMeter2026-Q399.784.0992.8Buyer-sourced0PASS
AX-2026-041599CJC-1295 (no DAC)QSCQSC-2606-V7416VendorInvestigate2026-Q397.963.52—Buyer-sourced1FAIL
AX-2026-041337SemaglutideWWBWWB-2606-N3192Nordanalyt2026-Q399.523.92—Buyer-sourced0PASS
AX-2026-043353LeuprolideWXTWXT-2604-K2596Janoshik2026-Q399.194.9095.3Laboratory-retained0PASS
AX-2026-042706SurvodutideERPERP-2605-E9865PeptideMeter2026-Q398.385.33103.5Buyer-sourced0PASS
AX-2026-043019AdipotideMKMMKM-2606-K5012Janoshik2026-Q397.615.77105.1Buyer-sourced0PASS
AX-2026-042595SemaglutideHJHJ-2608-C7002Janoshik2026-Q399.503.55—Buyer-sourced1MARGINAL
AX-2026-042226SS-31 (Elamipretide)TFCTFC-2607-R9099Janoshik2026-Q399.625.47—Buyer-sourced0PASS
AX-2026-042217SemaglutideTFCTFC-2604-X9037PeptideMeter2026-Q398.954.6196.9Buyer-sourced0PASS
AX-2026-042012GHRP-6AMBAMB-2603-S5667Janoshik2026-Q399.375.9088.8Laboratory-retained1MARGINAL